DECAMP Study 2 will involve two patient groups:
- Group A will include 50 study participants diagnosed with early-stage lung cancers and 30 study participants with benign (noncancerous or nonmalignant) lung nodules. Click Group A for more information.
- Group B will include approximately 800 study participants who are current or former smokers and have one additional risk factor for lung cancer. Click Group B for more information.